Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Paine S, Piepkorn MW, Prieto V, Rabkin MS, Schmidt B, Selim A, Shea CR, Trotter MJ. Barnhill RL, et al. Among authors: argenyi z. Am J Surg Pathol. 2008 Jan;32(1):36-44. doi: 10.1097/PAS.0b013e3181573aaf. Am J Surg Pathol. 2008. PMID: 18162768
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.
Shors AR, Kim S, White E, Argenyi Z, Barnhill RL, Duray P, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Rabkin MS, Schmidt B, Shea CR, Trotter MJ, Piepkorn MW. Shors AR, et al. Among authors: argenyi z. Br J Dermatol. 2006 Nov;155(5):988-93. doi: 10.1111/j.1365-2133.2006.07466.x. Br J Dermatol. 2006. PMID: 17034530 Free article.
Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: a case-control study.
Xiong MY, Rabkin MS, Piepkorn MW, Barnhill RL, Argenyi Z, Erickson L, Guitart J, Lowe L, Shea CR, Trotter MJ, Lew RA, Weinstock MA. Xiong MY, et al. Among authors: argenyi z. J Am Acad Dermatol. 2014 Dec;71(6):1257-1258.e4. doi: 10.1016/j.jaad.2014.07.030. Epub 2014 Nov 15. J Am Acad Dermatol. 2014. PMID: 25454033 No abstract available.
Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.
Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Vidal CI, et al. Among authors: argenyi z. J Cutan Pathol. 2018 Aug;45(8):563-580. doi: 10.1111/cup.13142. Epub 2018 Jun 7. J Cutan Pathol. 2018. PMID: 29566273 Free article.
Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.
Task Force/Committee Members; Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY; Rating Panel; Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Task Force/Committee Members, et al. Among authors: argenyi z. J Am Acad Dermatol. 2019 Jan;80(1):189-207.e11. doi: 10.1016/j.jaad.2018.04.033. Epub 2018 Apr 22. J Am Acad Dermatol. 2019. PMID: 29689323
121 results